EBPIT Trademark

Trademark Overview


On Thursday, February 27, 2020, a trademark application was filed for EBPIT with the United States Patent and Trademark Office. The USPTO has given the EBPIT trademark a serial number of 88813289. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, June 20, 2024. This trademark is owned by Angany Inc.. The EBPIT trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Protein arrays for medical diagnosis purposes; Protein arrays for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for treatment of cancer, allergies, autoimmune disease, infection disease

Chemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies for scientific, laboratory and medical research; proteins for immunoassay for detection, for diagnostic purposes, for therapeutic purposes, and for treatment of cancer, allergies, autoimmune disease, infection diseases

Medical services, namely, vaccinal pharmacologic treatment of autoimmune diseases such as psoriasis, Crohn's disease, rheumatoid arthritis, cancer, infectious diseases and allergies; health care services, namely, desensitization treatments for allergy; medical services, namely, immunotherapy in the fields of cancer, autoimmune, infectious disease and orphan diseases conditions in humans and veterinary applications; medical treatment of allergies, cancer, and auto-immune diseases destined to generate, in response to its administration in patients, the production of the patient's own antibodies

Development of pharmaceutical preparations and medicines; pharmaceutical research and development; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of vaccinal pharmacologic treatment and allergy medications; platform as a service (PAAS) services featuring artificial intelligence software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of vaccinal pharmacologic treatment and allergy medications
ebpit

General Information


Serial Number88813289
Word MarkEBPIT
Filing DateThursday, February 27, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, June 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProtein arrays for medical diagnosis purposes; Protein arrays for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for treatment of cancer, allergies, autoimmune disease, infection disease
Pseudo MarkE BPIT
Goods and ServicesChemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies for scientific, laboratory and medical research; proteins for immunoassay for detection, for diagnostic purposes, for therapeutic purposes, and for treatment of cancer, allergies, autoimmune disease, infection diseases
Goods and ServicesMedical services, namely, vaccinal pharmacologic treatment of autoimmune diseases such as psoriasis, Crohn's disease, rheumatoid arthritis, cancer, infectious diseases and allergies; health care services, namely, desensitization treatments for allergy; medical services, namely, immunotherapy in the fields of cancer, autoimmune, infectious disease and orphan diseases conditions in humans and veterinary applications; medical treatment of allergies, cancer, and auto-immune diseases destined to generate, in response to its administration in patients, the production of the patient's own antibodies
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; pharmaceutical research and development; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of vaccinal pharmacologic treatment and allergy medications; platform as a service (PAAS) services featuring artificial intelligence software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of vaccinal pharmacologic treatment and allergy medications

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAngany Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressQuebec (Quebec) G1R1R2
CA

Trademark Events


Event DateEvent Description
Thursday, March 5, 2020NEW APPLICATION ENTERED
Thursday, March 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 18, 2020ASSIGNED TO EXAMINER
Monday, May 18, 2020NON-FINAL ACTION WRITTEN
Monday, May 18, 2020NON-FINAL ACTION E-MAILED
Monday, May 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 12, 2021ASSIGNED TO LIE
Tuesday, February 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 18, 2021SUSPENSION LETTER WRITTEN
Thursday, February 18, 2021LETTER OF SUSPENSION E-MAILED
Thursday, February 18, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 12, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, April 12, 2021EXAMINERS AMENDMENT E-MAILED
Monday, April 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 12, 2021EXAMINER'S AMENDMENT ENTERED
Monday, April 12, 2021SUSPENSION LETTER WRITTEN
Monday, April 12, 2021LETTER OF SUSPENSION E-MAILED
Monday, April 12, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 12, 2021SUSPENSION INQUIRY WRITTEN
Tuesday, October 12, 2021INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 12, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 11, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 13, 2022ASSIGNED TO LIE
Thursday, April 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 19, 2022SUSPENSION LETTER WRITTEN
Tuesday, April 19, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, April 19, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 26, 2022ASSIGNED TO EXAMINER
Wednesday, November 23, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, December 1, 2022SUSPENSION INQUIRY WRITTEN
Thursday, December 1, 2022INQUIRY TO SUSPENSION E-MAILED
Thursday, December 1, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, May 4, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, June 29, 2023ASSIGNED TO EXAMINER
Monday, August 14, 2023SUSPENSION LETTER WRITTEN
Monday, August 14, 2023LETTER OF SUSPENSION E-MAILED
Monday, August 14, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 20, 2024SUSPENSION LETTER WRITTEN
Thursday, June 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 20, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 20, 2024LETTER OF SUSPENSION E-MAILED
Thursday, June 20, 2024ASSIGNED TO LIE
Friday, February 16, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, March 9, 2024SUSPENSION INQUIRY WRITTEN
Saturday, March 9, 2024INQUIRY TO SUSPENSION E-MAILED
Saturday, March 9, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, March 22, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED